| C08CA02 |
Felodipine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C08CA02 |
Felodipine |
AURONAL |
Prolonged‐release tablet |
5 |
mg |
30 |
EGIS Pharmaceuticals PLC, Унгария |
5 |
mg |
- |
12.06 |
0.07533 |
2.26 |
50% |
1.13 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.1,I20.8,I20.9 |
НСР-9523/09.06.2016. |
02.07.2016. |
08.09.2012 |
|
Активен |
416 |
3.62 |
| C08CA02 |
Felodipine |
AURONAL |
Prolonged‐release tablet |
2.5 |
mg |
30 |
EGIS Pharmaceuticals PLC, Унгария |
5 |
mg |
- |
7.45 |
0.07533 |
1.13 |
50% |
0.56 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.1,I20.8,I20.9 |
НСР-9525/09.06.2016. |
02.07.2016. |
08.09.2012 |
|
Активен |
415 |
1.81 |
| C08CA02 |
Felodipine |
AURONAL |
Prolonged‐release tablet |
10 |
mg |
30 |
EGIS Pharmaceuticals PLC, Унгария |
5 |
mg |
- |
19.5 |
0.07533 |
4.52 |
50% |
2.26 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.1,I20.8,I20.9 |
НСР-9524/09.06.2016. |
02.07.2016. |
08.09.2012 |
|
Активен |
414 |
7.23 |
| C08CA02 |
Felodipine |
Felicipin |
Prolonged‐release tablet |
5 |
mg |
30 |
Актавис EАД, България |
5 |
mg |
- |
8.46 |
0.07533 |
2.26 |
50% |
1.13 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.1,I20.8,I20.9 |
|
02.06.2015 |
08.09.2012 |
|
Активен |
208 |
3.62 |
| C08CA02 |
Felodipine |
Felodipine-Ratiopharm |
Prolonged‐release tablet |
5 |
mg |
30 |
Ratiopharm GmbH, Германия |
5 |
mg |
- |
6.3 |
0.21 |
6.3 |
50% |
3.15 |
|
I10,I11,I12,I13,I20 |
№25/03.08.2009; ; КЦРР-1847/12.12.2012 г; КЦРР-2935/20.03.2013 |
26.04.2013 |
08.09.2012 |
|
Заличен |
1571 |
|
| C08CA02 |
Felodipine |
Felodipine-Ratiopharm |
Prolonged‐release tablet |
10 |
mg |
30 |
Ratiopharm GmbH, Германия |
5 |
mg |
- |
13.12 |
0.21867 |
13.12 |
50% |
6.56 |
|
I10,I11,I12,I13,I20 |
№25/03.08.2009; ; КЦРР-1847/12.12.2012 г; КЦРР-2931/20.03.2013 |
26.04.2013 |
08.09.2012 |
|
Заличен |
1572 |
|
| C08CA02 |
Felodipine |
FELODIPINE-TCHAIKAPHARMA |
Prolonged‐release tablet |
5 |
mg |
30 |
Чайкафарма Висококачествените лекарства АД, България |
5 |
mg |
- |
7.06 |
0.07533 |
2.26 |
50% |
1.13 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.1,I20.8,I20.9 |
№ 66/ 08.04.2010; № 84/27.05.2010 |
02.06.2015 |
08.09.2012 |
|
Активен |
764 |
3.62 |
| C08CA02 |
Felodipine |
FeloHEXAL |
Prolonged‐release tablet |
10 |
mg |
30 |
Hexal AG, Германия |
5 |
mg |
- |
4.52 |
0.07533 |
4.52 |
50% |
2.26 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.1,I20.8,I20.9 |
КП-201/30.04.2015 и НСР-1817/25.11.2013 |
02.06.2015 |
08.09.2012 |
|
Активен |
3884 |
Без промяна |
| C08CA02 |
Felodipine |
FeloHEXAL |
Prolonged‐release tablet |
5 |
mg |
30 |
Hexal AG, Германия |
5 |
mg |
- |
6.86 |
0.07533 |
2.26 |
50% |
1.13 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.1,I20.8,I20.9 |
КЦРР-1285/21.08.2012 г.; НСР-7486/12.11.2015 |
02.12.2015 |
08.09.2012 |
|
Активен |
1361 |
3.62 |
| C08CA02 |
Felodipine |
Plendil |
Prolonged‐release tablet |
5 |
mg |
30 |
Astra Zeneca AB, Швеция |
5 |
mg |
- |
12.28 |
0.07533 |
2.26 |
50% |
1.13 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.1,I20.8,I20.9 |
КЦРР-491/19.04.2012 г.; НСР-3974/30.06.2014.; НСР-7514/19.11.2015. |
02.01.2016 |
08.09.2012 |
|
Активен |
2996 |
3.62 |
| C08CA02 |
Felodipine |
PRESID 10 MG |
Prolonged‐release tablet |
10 |
mg |
30 |
Teva Czech Industries s.r.o., Чешка република |
5 |
mg |
- |
12.48 |
0.07533 |
4.52 |
50% |
2.26 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.1,I20.8,I20.9 |
КЦРР-740/07.06.2012 г.; КЦРР-2837/20.03.2013 г.; НСР-3700/06.06.2014 |
02.06.2015 |
08.09.2012 |
|
Активен |
2913 |
7.23 |
| C08CA02 |
Felodipine |
PRESID 2,5 MG |
Prolonged‐release tablet |
2.5 |
mg |
30 |
Teva Czech Industries s.r.o., Чешка република |
5 |
mg |
- |
2.87 |
0.07533 |
1.13 |
50% |
0.57 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.1,I20.8,I20.9 |
КЦРР-740/07.06.2012 г.; КЦРР-2844/20.03.2013 г; НСР-2299/13.01.2014; НСР-4671/25.09.2014 |
02.06.2015 |
08.09.2012 |
|
Активен |
2464 |
1.81 |
| C08CA02 |
Felodipine |
PRESID 5 MG |
Prolonged‐release tablet |
5 |
mg |
30 |
Teva Czech Industries s.r.o., Чешка република |
5 |
mg |
- |
5.93 |
0.07533 |
2.26 |
50% |
1.13 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.1,I20.8,I20.9 |
КЦРР-740/07.06.2012 г.; КЦРР-2838/20.03.2013 г.; НСР-3700/06.06.2014.; НСР-6785/23.07.2015. |
16.08.2015 |
08.09.2012 |
|
Активен |
2912 |
3.62 |
| C08CA05 |
Nifedipine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C08CA05 |
Nifedipine |
Adalat Eins 30 |
Prolonged‐release tablet |
30 |
mg |
30 |
Bayer Pharma AG, Германия |
30 |
mg |
- |
14.54 |
0.12325 |
3.7 |
50% |
1.85 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.1,I20.8,I20.9 |
НСР-138/07.06.2013; НСР-2930/07.03.2014; НСР-7339/29.10.2015 |
02.12.2015 |
08.09.2012 |
|
Заличен |
1888 |
|
| C08CA05 |
Nifedipine |
Adalat Oros 30 |
Prolonged‐release tablet |
30 |
mg |
28 |
Bayer HealthCare AG,, Германия |
30 |
mg |
- |
21.59 |
0.13025 |
3.65 |
50% |
1.82 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.1,I20.8,I20.9 |
НСР-5560/29.01.2015 |
16.02.2015 |
08.09.2012 |
|
Заличен |
359 |
|
| C08CA05 |
Nifedipine |
Cordaflex |
Prolonged‐release tablet |
20 |
mg |
60 |
EGIS Pharmaceuticals PLC, Унгария |
30 |
mg |
- |
4.93 |
0.12325 |
4.93 |
50% |
2.46 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.1,I20.8,I20.9 |
НСР-3551/16.05.2014; КП-29/05.03.2015 и НСР-1520/25.10.2013 |
02.04.2015 |
08.09.2012 |
|
Активен |
3646 |
Без промяна |
| C08CA05 |
Nifedipine |
Cordaflex |
Prolonged‐release tablet |
20 |
mg |
30 |
EGIS Pharmaceuticals PLC, Унгария |
30 |
mg |
- |
3.74 |
0.12325 |
2.47 |
50% |
1.23 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.1,I20.8,I20.9 |
|
02.04.2015 |
08.09.2012 |
|
Активен |
370 |
Без промяна |
| C08CA05 |
Nifedipine |
CORINFAR |
Prolonged‐release tablet |
20 |
mg |
30 |
Екофарм Груп АД, България |
30 |
mg |
- |
3.34 |
0.12325 |
2.47 |
50% |
1.23 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.1,I20.8,I20.9 |
КЦPP-813/15.06.2012 г.НСР-3347/24.04.2014; НСР-3279/24.04.2014 |
02.04.2015 |
08.09.2012 |
|
Активен |
2755 |
Без промяна |
| C08CA05 |
Nifedipine |
KORINCARE |
Prolonged‐release tablet |
20 |
mg |
20 |
Чайкафарма Висококачествените лекарства АД, България |
30 |
mg |
- |
2.75 |
0.12325 |
1.64 |
50% |
0.82 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.1,I20.8,I20.9 |
НСР-2411/21.01.2014 |
02.04.2015 |
08.09.2012 |
|
Активен |
2528 |
Без промяна |
| C08CA05 |
Nifedipine |
NIFEDIPIN ACTAVIS |
Film‐coated tablet |
10 |
mg |
50 |
Актавис EАД, България |
30 |
mg |
- |
2.89 |
0.12325 |
2.05 |
50% |
1.02 |
за краткосрочно лечение |
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.1,I20.8,I20.9 |
|
02.04.2015 |
08.09.2012 |
|
Активен |
234 |
Без промяна |
| C08CA06 |
Nimodipine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C08CA06 |
Nimodipine |
NIMOTOP S |
Film‐coated tablet |
30 |
mg |
100 |
Bayer Pharma AG, Германия |
300 |
mg |
- |
31.98 |
3.198 |
31.98 |
50% |
15.99 |
|
I69.0 |
НСР-210/18.06.2013; НСР-2929/07.03.2014; НСР-8324/26.02.2016 |
02.04.2016 |
08.09.2012 |
|
Активен |
1889 |
Без промяна |
| C08CA08 |
Nitrendipine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|